These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23625977)

  • 21. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
    Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA
    Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.
    Rajamannan NM; Subramaniam M; Springett M; Sebo TC; Niekrasz M; McConnell JP; Singh RJ; Stone NJ; Bonow RO; Spelsberg TC
    Circulation; 2002 Jun; 105(22):2660-5. PubMed ID: 12045173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
    Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
    Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
    Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.
    Barbosa SP; Lins LC; Fonseca FA; Matos LN; Aguirre AC; Bianco HT; Amaral JB; França CN; Santana JM; Izar MC
    Life Sci; 2013 May; 92(14-16):845-51. PubMed ID: 23507424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
    Azar RR; Badaoui G; Sarkis A; Azar M; Aydanian H; Harb S; Achkouty G; Kassab R
    Am J Cardiol; 2010 Jul; 106(2):193-7. PubMed ID: 20599002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis.
    Farnaghi S; Prasadam I; Cai G; Friis T; Du Z; Crawford R; Mao X; Xiao Y
    FASEB J; 2017 Jan; 31(1):356-367. PubMed ID: 27737897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA; Joy MS; Denu-Ciocca CJ; Chin H; Hogan SL; Pieper JA
    Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.
    Gierman LM; van der Ham F; Koudijs A; Wielinga PY; Kleemann R; Kooistra T; Stoop R; Kloppenburg M; van Osch GJ; Stojanovic-Susulic V; Huizinga TW; Zuurmond AM
    Arthritis Rheum; 2012 Apr; 64(4):1172-81. PubMed ID: 22034049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs.
    Aggarwal D; West KL; Zern TL; Shrestha S; Vergara-Jimenez M; Fernandez ML
    BMC Cardiovasc Disord; 2005 Sep; 5():30. PubMed ID: 16188040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase.
    Kassai A; Illyés L; Mirdamadi HZ; Seres I; Kalmár T; Audikovszky M; Paragh G
    Clin Biochem; 2007 Jan; 40(1-2):1-5. PubMed ID: 16999950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits.
    Verd JC; Peris C; Alegret M; Díaz C; Hernández G; Vázquez M; Adzet T; Laguna JC; Sánchez RM
    Br J Pharmacol; 1999 Jul; 127(6):1479-85. PubMed ID: 10455299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
    Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
    Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.
    Barrios V; Amabile N; Paganelli F; Chen JW; Allen C; Johnson-Levonas AO; Massaad R; Vandormael K
    Int J Clin Pract; 2005 Dec; 59(12):1377-86. PubMed ID: 16351668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.
    Momi S; Monopoli A; Alberti PF; Falcinelli E; Corazzi T; Conti V; Miglietta D; Ongini E; Minuz P; Gresele P
    Cardiovasc Res; 2012 Jun; 94(3):428-38. PubMed ID: 22362817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.